MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats-Reference-Cited by-同舟云学术

MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats

Published:2007-10 Issue:10 Volume:28 Page:2009-2015
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Castellano Jessica M.,Batrynchuk Jody,Dolbeare Kristine,Verma Vaneeta,Mann Amandeep,Skoblenick Kevin J.,Johnson Rodney L.,Mishra Ram K.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference52 articles.

1. From the cover: increased baseline occupancy of D2 receptors by dopamine in schizophrenia;Abi-Dargham;Proc Natl Acad Sci USA,2000

2. Potentiation of levodopa effect by intravenous l-prolyl-l-leucyl-glycine amide in man;Barbeau;Lancet,1975

3. Peptides in Parkinson's disease;Barbeau;Adv Exp Med Biol,1978

4. The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites;Bhargava;Gen Pharmacol,1983

5. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence;Carlsson;Annu Rev Pharmacol Toxicol,2001

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Chronic Treatment with D2 Allosteric Modulator PAOPA on the Expression of Cerebral Dopamine Neurotrophic Factor (CDNF) in Select Brain Regions;International Journal of Peptide Research and Therapeutics;2021-08-19

2. Change in expression of vesicular protein synapsin II by chronic treatment with D2 allosteric modulator PAOPA;Peptides;2015-04

3. Effects of the Dopamine D2 Allosteric Modulator, PAOPA, on the Expression of GRK2, Arrestin-3, ERK1/2, and on Receptor Internalization;PLoS ONE;2013-08-06

4. Synthesis of an MIF-1 analogue containing enantiopure ( S )-α-trifluoromethyl-proline and biological evaluation on nociception;European Journal of Medicinal Chemistry;2013-04

5. Preclinical pharmacokinetic and toxicological evaluation of MIF-1 peptidomimetic, PAOPA: Examining the pharmacology of a selective dopamine D2 receptor allosteric modulator for the treatment of schizophrenia;Peptides;2013-04